EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Helile formula from “Tai ping sheng hui fang”: anti-Helicobacter pylori activity, gut microbiota modulation, and inflammatory response regulation

Ling Ou, Meiyun Chen, Chang Peng, Haobo Chen, Yajie Hao, Qingchang Chen, Zhong Feng, Meicun Yao, Xianhe Kong

Frontiers in Cellular and Infection Microbiology · 2025

DOI: 10.3389/fcimb.2025.1603128 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2025. Verfasst von Ling Ou und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences (Shenzhen), Sun Yat-sen University, Shenzhen, Guangdong, China. Hauptthemen laut MEDLINE: Helicobacter pylori, Gastrointestinal Microbiome, Helicobacter Infections, Anti-Bacterial Agents. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Helicobacter pylori (HP) is a major gastric pathogen linked to chronic gastritis, peptic ulcers, and gastric cancer. The emergence of antibiotic resistance has prompted the search for alternative treatments. Helile formula, derived from the ancient “Taiping Shenghuifang,” is known to treat various degrees of diarrhea and has potential for treating gastrointestinal disorders. However, the antibacterial efficacy, material basis, and action mechanisms of the helile formula against HP remain undetermined.

Methods

The chemical constituents were analyzed using ultra-high-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) and high-performance liquid chromatography (HPLC). The in vitro anti-HP activity and underlying mechanisms were investigated through a series of assays, including the determination of minimum inhibitory concentration (MIC), N-phenyl-1-naphthylamine (NPN) uptake assay, scanning electron microscopy (SEM) to observe morphological changes, cell viability and cell adhesion activity assays, assessment of nitric oxide (NO) production, and reverse transcription-quantitative polymerase chain reaction (RT-qPCR) for gene expression analysis. For the in vivo anti-HP infection study and mechanism exploration, techniques such as hematoxylin and eosin (H&E) staining for histological examination, enzyme-linked immunosorbent assay (ELISA) for cytokine and antibody quantification, 16S ribosomal DNA (16S rDNA) sequencing for microbial community profiling, and metabolomics for global metabolite analysis were employed.

Results

Multiple constituents of helile formula, namely ellagic acid, gallic acid, chebulagic acid, chebulic acid, and corilagin, were identified. In vitro , helile formula increased bacterial outer-membrane permeability, disrupted HP structure, inhibited toxin-related genes, and suppressed cell adhesion. In male Kunming mice, helile formula effectively reversed HP-induced inflammation. It modulated key metabolites, such as adenine, panaxytriol, 4-hydroxyglutamate semialdehyde, and N-alpha-Acetyl-L-lysine. It influenced the gut microbiota, especially families like Muribaculaceae and Lactobacillaceae . Adenine, in particular, repaired HP-caused damage to GES1 cells, reduced HP - mediated cell adhesion, and inhibited HP-induced interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α) production.

Conclusion

These findings demonstrated the remarkable anti-HP efficacy of the helile formula in vitro and in vivo , suggesting that the helile formula represents a highly promising therapeutic candidate for the management of HP infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Helicobacter pyloriGastrointestinal MicrobiomeHelicobacter InfectionsAnti-Bacterial AgentsDrugs, Chinese HerbalAnimalsMiceMicrobial Sensitivity TestsDisease Models, AnimalHumansNitric OxideMaleCell SurvivalInflammationTandem Mass SpectrometryCytokines

Stichwörter der Autor:innen

Helicobacter pyloriantibacterial activityhelile formulamaterial basismechanism

Substanzen

Anti-Bacterial AgentsDrugs, Chinese HerbalNitric OxideCytokines

Autor:innen und Institutionen

  • School of Pharmaceutical Sciences (Shenzhen), Sun Yat-sen University, Shenzhen, Guangdong, China.
  • Discipline of Chinese and Western Integrative Medicine, Jiangxi University of Chinese Medicine, Nanchang, China.
  • International Pharmaceutical Engineering Lab of Shandong Province, Feixian, Shandong, China.
  • Department of Biomedical Engineering, College of Design and Engineering, National University of Singapore, Singapore, Singapore.
  • Nanchang Research Institute, Sun Yat-sen University, Jiangxi, China.
  • Clinical Medical Research Center for Plateau Gastroenterological Disease of Xizang Autonomous Region, Affiliated Hospital of Xizang Minzu University, Xianyang, Shanxi, China.

Zitieren

APA

Ou, L., Chen, M., Peng, C., Chen, H., Hao, Y., Chen, Q., Feng, Z., Yao, M., & Kong, X. (2025). Helile formula from “Tai ping sheng hui fang”: anti-Helicobacter pylori activity, gut microbiota modulation, and inflammatory response regulation. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2025.1603128

Vancouver

Ou L, Chen M, Peng C, Chen H, Hao Y, Chen Q, et al. Helile formula from “Tai ping sheng hui fang”: anti-Helicobacter pylori activity, gut microbiota modulation, and inflammatory response regulation. Frontiers in Cellular and Infection Microbiology. 2025. doi:10.3389/fcimb.2025.1603128

BibTeX
@article{Ou2025,
  author = {Ou, Ling and Chen, Meiyun and Peng, Chang and Chen, Haobo and Hao, Yajie and Chen, Qingchang and Feng, Zhong and Yao, Meicun and Kong, Xianhe},
  title = {Helile formula from “Tai ping sheng hui fang”: anti-Helicobacter pylori activity, gut microbiota modulation, and inflammatory response regulation},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2025},
  doi = {10.3389/fcimb.2025.1603128}
}
Kostenlos starten →